- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Samsung Biologics Product Carbon Footprint System Validated by Third Party | ||
| Fr | Lilly 4Q Results | ||
| Fr | Eisai, Henlius Strike Japan Commercialization Deal for PD-1 Antibody Serplulimab | ||
| Fr | FDA Grants Priority Review for Pfizer's HYMPAVZI | ||
| Do | Pfizer 4Q Results | ||
| Do | ADARx Pharmaceuticals Appoints Donald Fong as CMO | ||
| Do | Sanofi 4Q Results | ||
| Do | Braveheart Bio Promotes CSO, Names New SVP | ||
| Do | AbbVie Submits Regulatory Applications for Rinvoq in Patients with Vitiligo | ||
| Mi | Novo Nordisk FY25 Results | ||
| Mi | OXB and BMS Expand Partnership With Lentiviral Vectors for CAR-T Programs | ||
| Mi | Merck 4Q Results | ||
| Mi | Biomica and Lishan Biotech Ink License Agreement for Microbiome-Based Cancer Therapeutic | ||
| Mi | HighRes, Opentrons to Launch First AI Agent-to-Agent Lab Workflow | ||
| Mi | Charles River Laboratories to Close Maryland Cell Therapy Site, Cut 20 Jobs | ||
| Mi | Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs | ||
| Mi | Bracco Imaging Expands into the Cell Therapy Space | ||
| Mi | BioMedX Appoints Nico Frisch as VP, Site Head Heidelberg | ||
| Mi | Pharmagene Discovery Services Launches Human Tissue Lab Biz | ||
| Di | CDR-Life Appoints Dimitrios Chondros as CMO | ||
| Di | AGC Biologics Seattle Site Receives Anvisa GMP Certification | ||
| Di | Spruce Biosciences Makes Two SVP Appointments | ||
| Di | Cellares, Stanford University Partner to Expand Automated Manufacturing Beyond T Cell Therapies | ||
| Di | Valo Health Names New CSO, Karin Conde-Knape | ||
| Di | Cycle Group Holdings Acquires Applied Therapeutics |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.